Cutera Introduces Pearl Laser Skin Rejuvenation
BRISBANE, Calif., March 28, 2007 — Cutera, Inc.® (Nasdaq: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today announced FDA clearance for its new laser, Pearl, with proprietary YSGG technology. Pearl is cleared for the treatment of wrinkles and represents the first application of the 2790 nm wavelength for cosmetic dermatology.
During treatment, Pearl removes a portion of the epidermis with a controlled thermal effect. The thermal effect creates a natural protective dressing on the skin to minimize downtime during the restorative process.
"What differentiates Pearl from traditional resurfacing products is its ability to denature a controlled depth of epidermis with minimal immediate tissue removal at the skin’s surface," said E. Victor Ross, MD, board-certified dermatologist at Scripps Medical Center in San Diego. "This is an important benefit for restoring the skin’s structure and vitality."
"We chose the YSGG wavelength because our current and prospective customers want a more aggressive solution to complement our non-ablative, no-downtime procedures," said Cutera President and CEO, Kevin Connors. "By introducing Pearl, we are entering into an emerging aesthetic market segment currently estimated at approximately $150 million per year and projected to be growing in excess of 30% per year."